A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Participants With Metastatic Prostate Cancer

NCT03748641 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

765

Enrollment

INDUSTRY

Sponsor class

Conditions

Castration-Resistant Prostatic Cancer

Interventions

DRUG: Niraparib
DRUG: Abiraterone Acetate
DRUG: Prednisone
DRUG: Placebo
DRUG: New Formulation of Niraparib and Abiraterone Acetate (AA)

Sponsor

Janssen Research & Development, LLC